Drug intelligence / Profile preview

Nervoprime-AQ

Development stage
Unknown
Lead developer
Puremed Biotech
Modality
Small Molecules
Administration
Intramuscular, Intravenous
01

Overview

Nervoprime-AQ is a veterinary pharmaceutical product developed and marketed by Pure Med Farma (Pure Med Biotech). It is an aqueous formulation of methylcobalamin (mecobalamin), a coenzyme form of Vitamin B12, provided in a pre-filled syringe (PFS) for parenteral administration. The "AQ" designation typically indicates an aqueous base, which is designed to be less painful upon injection compared to traditional formulations. Methylcobalamin is essential for the maintenance of the nervous system, acting as a cofactor for the enzyme methionine synthase, which is involved in the conversion of homocysteine to methionine. This process is critical for DNA synthesis and the formation and maintenance of the myelin sheath. In veterinary medicine, Nervoprime-AQ is primarily used to treat peripheral neuropathies, neurological disorders, megaloblastic anemia, and general weakness in livestock and companion animals.

Brand names
Nervoprime-AQ
Other names
Nervoprime-AQ Pfs Injection
02

Targets

MTR (Methionine synthase)

Beyond the preview

Go deeper on Nervoprime-AQ.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nervoprime-AQ.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call